Directory
>
Ken Prentice
Ken Prentice
Student Research Assistant | Shape Therapeutics Inc.
Washington, Seattle, United States
Ken Prentice
Summary
Ken Prentice is an accomplished executive with over 20 years of experience in biotherapeutic drug development, currently serving as Vice President at Shape Therapeutics, Inc. His career has been marked by significant contributions to protein research, technology and method development, and regulatory submissions, particularly in the realm of advanced therapies like CAR-T and rAAV gene therapy. Ken is known for his ability to build and lead high-performing teams that drive innovation and establish best practices across diverse modalities. His technical expertise spans a wide range of analytical techniques and quality control processes, enabling him to effectively navigate the complexities of drug development. Beyond his technical skills, he has a strong focus on strategic leadership and fostering a culture of collaboration within his teams. Ken's educational background in Chemistry and Oceanography from the University of Washington complements his extensive hands-on experience in the pharmaceutical industry. He is passionate about advancing therapeutic solutions that address unmet medical needs.
Ken Prentice
Work Experience
Senior Vice President, Head of Process Development and Manufacturing at
Shape Therapeutics Inc.
July 2024 - Present
Ken Prentice
Education
University of Washington, BS, Chemistry and Oceanography
January 1995 - January 2000
Frequently Asked Questions about Ken Prentice
What is Ken Prentice email address?
Ken Prentice's primary email address is ************@junotherapeutics.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Ken Prentice work for?
Ken Prentice is a Student Research Assistant at Shape Therapeutics Inc..
Where Ken Prentice graduated from?
Ken Prentice holds a degree in null from University of Washington.
How can I directly contact Ken Prentice?
To contact Ken Prentice directly, you can use the email address ************@junotherapeutics.com. Complete contact information is available upon registration with Muraena.
Who is Ken Prentice?
Ken Prentice is an accomplished executive with over 20 years of experience in biotherapeutic drug development, currently serving as Vice President at Shape Therapeutics, Inc. His career has been marked by significant contributions to protein research, technology and method development, and regulatory submissions, particularly in the realm of advanced therapies like CAR-T and rAAV gene therapy. Ken is known for his ability to build and lead high-performing teams that drive innovation and establish best practices across diverse modalities. His technical expertise spans a wide range of analytical techniques and quality control processes, enabling him to effectively navigate the complexities of drug development. Beyond his technical skills, he has a strong focus on strategic leadership and fostering a culture of collaboration within his teams. Ken's educational background in Chemistry and Oceanography from the University of Washington complements his extensive hands-on experience in the pharmaceutical industry. He is passionate about advancing therapeutic solutions that address unmet medical needs.
Ken`s contact details
************@junotherapeutics.com
Colleagues
Account Manager and Technical Recruiter
Summer Analyst
EMBO postdoctoral research fellow
Human Resources Assistant